Very encouraging for mine ,late stage cancer.
Durable response ,72% progression free at 6 months...part A
Part B
Partial response rate of 50% in high risk patients ,partial response often means greater than 50% tumour shrinkage , after 3 months,,current disease control rate 4/6 or 66% of patients ,no toxicity ,once again very impressive for mine ,only a small number of patients but that was always the case ,it’s only a phase 1 trial.
If these percentages can be translated to greater numbers that would be very exciting.
- Forums
- ASX - By Stock
- IMM
- Ann: Immutep presents new TACTI-mel data at ICI Europe Summit
Ann: Immutep presents new TACTI-mel data at ICI Europe Summit, page-6
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
36.3¢ |
Change
-0.003(0.68%) |
Mkt cap ! $526.5M |
Open | High | Low | Value | Volume |
36.5¢ | 36.5¢ | 36.0¢ | $46.62K | 128.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 46504 | 36.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.5¢ | 111260 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 46534 | 0.360 |
12 | 95057 | 0.355 |
13 | 222900 | 0.350 |
9 | 56219 | 0.345 |
8 | 100965 | 0.340 |
Price($) | Vol. | No. |
---|---|---|
0.365 | 57229 | 9 |
0.370 | 153117 | 8 |
0.375 | 73723 | 7 |
0.380 | 110250 | 7 |
0.385 | 140660 | 11 |
Last trade - 10.58am 27/08/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |